1 Introduction to Research & Analysis Reports
1.1 Antiandrogen Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiandrogen Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiandrogen Overall Market Size
2.1 Global Antiandrogen Market Size: 2022 VS 2029
2.2 Global Antiandrogen Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antiandrogen Players in Global Market
3.2 Top Global Antiandrogen Companies Ranked by Revenue
3.3 Global Antiandrogen Revenue by Companies
3.4 Top 3 and Top 5 Antiandrogen Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antiandrogen Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiandrogen Players in Global Market
3.6.1 List of Global Tier 1 Antiandrogen Companies
3.6.2 List of Global Tier 2 and Tier 3 Antiandrogen Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Antiandrogen Market Size Markets, 2022 & 2029
4.1.2 Steroidal Antiandrogen
4.1.3 Nonsteroidal Antiandrogen
4.2 By Type – Global Antiandrogen Revenue & Forecasts
4.2.1 By Type – Global Antiandrogen Revenue, 2018-2023
4.2.2 By Type – Global Antiandrogen Revenue, 2024-2029
4.2.3 By Type – Global Antiandrogen Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antiandrogen Market Size, 2022 & 2029
5.1.2 Prostate Cancer
5.1.3 Benign Prostatic Hyperplasia
5.1.4 Polycystic Ovary Syndrome (POCS)
5.1.5 Others
5.2 By Application – Global Antiandrogen Revenue & Forecasts
5.2.1 By Application – Global Antiandrogen Revenue, 2018-2023
5.2.2 By Application – Global Antiandrogen Revenue, 2024-2029
5.2.3 By Application – Global Antiandrogen Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Antiandrogen Market Size, 2022 & 2029
6.2 By Region – Global Antiandrogen Revenue & Forecasts
6.2.1 By Region – Global Antiandrogen Revenue, 2018-2023
6.2.2 By Region – Global Antiandrogen Revenue, 2024-2029
6.2.3 By Region – Global Antiandrogen Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Antiandrogen Revenue, 2018-2029
6.3.2 US Antiandrogen Market Size, 2018-2029
6.3.3 Canada Antiandrogen Market Size, 2018-2029
6.3.4 Mexico Antiandrogen Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Antiandrogen Revenue, 2018-2029
6.4.2 Germany Antiandrogen Market Size, 2018-2029
6.4.3 France Antiandrogen Market Size, 2018-2029
6.4.4 U.K. Antiandrogen Market Size, 2018-2029
6.4.5 Italy Antiandrogen Market Size, 2018-2029
6.4.6 Russia Antiandrogen Market Size, 2018-2029
6.4.7 Nordic Countries Antiandrogen Market Size, 2018-2029
6.4.8 Benelux Antiandrogen Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Antiandrogen Revenue, 2018-2029
6.5.2 China Antiandrogen Market Size, 2018-2029
6.5.3 Japan Antiandrogen Market Size, 2018-2029
6.5.4 South Korea Antiandrogen Market Size, 2018-2029
6.5.5 Southeast Asia Antiandrogen Market Size, 2018-2029
6.5.6 India Antiandrogen Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Antiandrogen Revenue, 2018-2029
6.6.2 Brazil Antiandrogen Market Size, 2018-2029
6.6.3 Argentina Antiandrogen Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Antiandrogen Revenue, 2018-2029
6.7.2 Turkey Antiandrogen Market Size, 2018-2029
6.7.3 Israel Antiandrogen Market Size, 2018-2029
6.7.4 Saudi Arabia Antiandrogen Market Size, 2018-2029
6.7.5 UAE Antiandrogen Market Size, 2018-2029
7 Antiandrogen Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Antiandrogen Major Product Offerings
7.1.4 Pfizer Antiandrogen Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Antiandrogen Major Product Offerings
7.2.4 Johnson & Johnson Antiandrogen Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Antiandrogen Major Product Offerings
7.3.4 AstraZeneca Antiandrogen Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Astellas
7.4.1 Astellas Company Summary
7.4.2 Astellas Business Overview
7.4.3 Astellas Antiandrogen Major Product Offerings
7.4.4 Astellas Antiandrogen Revenue in Global Market (2018-2023)
7.4.5 Astellas Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Antiandrogen Major Product Offerings
7.5.4 Merck Antiandrogen Revenue in Global Market (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Antiandrogen Major Product Offerings
7.6.4 Sanofi Antiandrogen Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Orion Corporation
7.7.1 Orion Corporation Company Summary
7.7.2 Orion Corporation Business Overview
7.7.3 Orion Corporation Antiandrogen Major Product Offerings
7.7.4 Orion Corporation Antiandrogen Revenue in Global Market (2018-2023)
7.7.5 Orion Corporation Key News & Latest Developments
7.8 Hengrui
7.8.1 Hengrui Company Summary
7.8.2 Hengrui Business Overview
7.8.3 Hengrui Antiandrogen Major Product Offerings
7.8.4 Hengrui Antiandrogen Revenue in Global Market (2018-2023)
7.8.5 Hengrui Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Company Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Antiandrogen Major Product Offerings
7.9.4 Bayer Antiandrogen Revenue in Global Market (2018-2023)
7.9.5 Bayer Key News & Latest Developments
7.10 Schering-Plough
7.10.1 Schering-Plough Company Summary
7.10.2 Schering-Plough Business Overview
7.10.3 Schering-Plough Antiandrogen Major Product Offerings
7.10.4 Schering-Plough Antiandrogen Revenue in Global Market (2018-2023)
7.10.5 Schering-Plough Key News & Latest Developments
7.11 Hinova Pharma
7.11.1 Hinova Pharma Company Summary
7.11.2 Hinova Pharma Business Overview
7.11.3 Hinova Pharma Antiandrogen Major Product Offerings
7.11.4 Hinova Pharma Antiandrogen Revenue in Global Market (2018-2023)
7.11.5 Hinova Pharma Key News & Latest Developments
7.12 Jiangsu Hengrui Pharmaceuticals
7.12.1 Jiangsu Hengrui Pharmaceuticals Company Summary
7.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview
7.12.3 Jiangsu Hengrui Pharmaceuticals Antiandrogen Major Product Offerings
7.12.4 Jiangsu Hengrui Pharmaceuticals Antiandrogen Revenue in Global Market (2018-2023)
7.12.5 Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Antiandrogen Market Opportunities & Trends in Global Market
Table 2. Antiandrogen Market Drivers in Global Market
Table 3. Antiandrogen Market Restraints in Global Market
Table 4. Key Players of Antiandrogen in Global Market
Table 5. Top Antiandrogen Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antiandrogen Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antiandrogen Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antiandrogen Product Type
Table 9. List of Global Tier 1 Antiandrogen Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiandrogen Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Antiandrogen Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Antiandrogen Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antiandrogen Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Antiandrogen Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Antiandrogen Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antiandrogen Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Antiandrogen Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Antiandrogen Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antiandrogen Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Antiandrogen Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antiandrogen Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Antiandrogen Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antiandrogen Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Antiandrogen Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antiandrogen Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Antiandrogen Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antiandrogen Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Antiandrogen Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antiandrogen Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Antiandrogen Product Offerings
Table 32. Pfizer Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Antiandrogen Product Offerings
Table 36. Johnson & Johnson Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Antiandrogen Product Offerings
Table 40. AstraZeneca Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Astellas Company Summary
Table 43. Astellas Antiandrogen Product Offerings
Table 44. Astellas Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 45. Astellas Key News & Latest Developments
Table 46. Merck Company Summary
Table 47. Merck Antiandrogen Product Offerings
Table 48. Merck Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Antiandrogen Product Offerings
Table 52. Sanofi Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Orion Corporation Company Summary
Table 55. Orion Corporation Antiandrogen Product Offerings
Table 56. Orion Corporation Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 57. Orion Corporation Key News & Latest Developments
Table 58. Hengrui Company Summary
Table 59. Hengrui Antiandrogen Product Offerings
Table 60. Hengrui Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 61. Hengrui Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Antiandrogen Product Offerings
Table 64. Bayer Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Schering-Plough Company Summary
Table 67. Schering-Plough Antiandrogen Product Offerings
Table 68. Schering-Plough Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 69. Schering-Plough Key News & Latest Developments
Table 70. Hinova Pharma Company Summary
Table 71. Hinova Pharma Antiandrogen Product Offerings
Table 72. Hinova Pharma Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 73. Hinova Pharma Key News & Latest Developments
Table 74. Jiangsu Hengrui Pharmaceuticals Company Summary
Table 75. Jiangsu Hengrui Pharmaceuticals Antiandrogen Product Offerings
Table 76. Jiangsu Hengrui Pharmaceuticals Antiandrogen Revenue (US$, Mn) & (2018-2023)
Table 77. Jiangsu Hengrui Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Antiandrogen Segment by Type in 2022
Figure 2. Antiandrogen Segment by Application in 2022
Figure 3. Global Antiandrogen Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antiandrogen Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Antiandrogen Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiandrogen Revenue in 2022
Figure 8. By Type - Global Antiandrogen Revenue Market Share, 2018-2029
Figure 9. By Application - Global Antiandrogen Revenue Market Share, 2018-2029
Figure 10. By Type - Global Antiandrogen Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Antiandrogen Revenue Market Share, 2018-2029
Figure 12. By Application - Global Antiandrogen Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Antiandrogen Revenue Market Share, 2018-2029
Figure 14. By Region - Global Antiandrogen Revenue Market Share, 2018-2029
Figure 15. By Country - North America Antiandrogen Revenue Market Share, 2018-2029
Figure 16. US Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Antiandrogen Revenue Market Share, 2018-2029
Figure 20. Germany Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 21. France Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Antiandrogen Revenue Market Share, 2018-2029
Figure 28. China Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 32. India Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Antiandrogen Revenue Market Share, 2018-2029
Figure 34. Brazil Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Antiandrogen Revenue Market Share, 2018-2029
Figure 37. Turkey Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Antiandrogen Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Astellas Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sanofi Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Orion Corporation Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hengrui Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bayer Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Schering-Plough Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hinova Pharma Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Jiangsu Hengrui Pharmaceuticals Antiandrogen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
